Clinical Trials
6 trialsNCT01907230 2019-03-13
Entecavir for Biological Agents Associated HBV Reactivation in Inflammatory Arthritis Patients
Taipei Veterans General Hospital, Taiwan
Phase 4 Unknown
NCT01765231 2017-01-10
Prophylactic Use of Entecavir for HBsAg Negative/HBcAb Positive/Hepatitis B Virus DNA Negative Patients With Lymphoma
Peking University
Phase 4 Unknown
NCT01768195 2017-01-10
Prophylactic Use of Entecavir for HBsAg Positive Lymphoma Patients Treated With Rituximab-based Immunochemotherapy
Peking University
Phase 4 Unknown
NCT01894269 2013-07-23
Chemoembolization With or Without Antiviral Therapy for Unresectable HBV-related HCC With Low HBV DNA Replication
Sun Yat-sen University
Phase 4 Unknown
NCT00555334 2009-04-01
LAM-RFA
Sun Yat-sen University
Phase 4 Unknown
NCT00768157 2009-02-09
Efficacy of Antiviral Therapy After Radical Resection for Hepatitis B Virus-Related Hepatocellular Carcinoma
Sun Yat-sen University
Phase 4 Unknown